Cost-effectiveness analysis of pre-ART HIV drug resistance testing in Kenyan women

BACKGROUND: The prevalence of pre-treatment drug resistance (PDR) to non-nucleoside reverse-transcriptase inhibitor (NNRTI) agents is increasing in sub-Saharan Africa, which may decrease the effectiveness of efavirenz-based antiretroviral therapy (ART) programs. However, due to recent safety concern...

Descripción completa

Detalles Bibliográficos
Autores principales: Duarte, Horacio A., Babigumira, Joseph B., Enns, Eva A., Stauffer, David C., Shafer, Robert W., Beck, Ingrid A., Garrison, Louis P., Chung, Michael H., Frenkel, Lisa M., Bendavid, Eran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256304/
https://www.ncbi.nlm.nih.gov/pubmed/32490370
http://dx.doi.org/10.1016/j.eclinm.2020.100355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256304/
https://www.ncbi.nlm.nih.gov/pubmed/32490370
http://dx.doi.org/10.1016/j.eclinm.2020.100355

Ejemplares similares